Funds holding Bliss Gvs Pharma Ltd
ISIN INE416D01022 · India · LEI 335800GXY3YCGGP7KJ45
- Fund holders
- 14
- Of which ETFs
- 9 5 other funds
- Value held
- 1.9M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Avantis Emerging Markets Equity ETF American Century ETF Trust | 197,350 | 460.2K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 161,555 | 472.9K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional Emerging Markets Core Equity 2 ETF Dimensional ETF Trust | 83,789 | 244.3K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| DIMENSIONAL EMERGING MARKETS VALUE FUND DIMENSIONAL EMERGING MARKETS VALUE FUND | 75,416 | 220.8K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional Emerging Markets Value ETF Dimensional ETF Trust | 42,633 | 124.3K $ | 0.01 % | as of Apr 30, 2026 ↗ |
| Dimensional World ex. U.S. Core Equity 2 ETF Dimensional ETF Trust | 39,050 | 113.9K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional Emerging Core Equity Market ETF Dimensional ETF Trust | 38,851 | 113.3K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Avantis Emerging Markets Equity Fund American Century ETF Trust | 23,549 | 54.9K $ | 0.01 % | as of Feb 28, 2026 ↗ |
| World ex U.S. Targeted Value Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 9,129 | 26.7K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Emerging Markets ex China Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 7,243 | 21.2K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Avantis Emerging Markets ex-China Equity ETF American Century ETF Trust | 6,689 | 15.6K $ | 0.01 % | as of Feb 28, 2026 ↗ |
| Avantis Emerging Markets Small Cap Equity ETF American Century ETF Trust | 5,011 | 11.7K $ | 0.01 % | as of Feb 28, 2026 ↗ |
| Dimensional Emerging Markets Sustainability Core 1 ETF Dimensional ETF Trust | 4,229 | 12.3K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional Emerging Markets ex China Core Equity ETF Dimensional ETF Trust | 136 | 396.6 $ | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Avantis Emerging Markets Small Cap Equity ETF American Century ETF Trust | 0.01 % | as of Feb 28, 2026 ↗ |
| Dimensional Emerging Markets Value ETF Dimensional ETF Trust | 0.01 % | as of Apr 30, 2026 ↗ |
| Avantis Emerging Markets Equity Fund American Century ETF Trust | 0.01 % | as of Feb 28, 2026 ↗ |
| Avantis Emerging Markets ex-China Equity ETF American Century ETF Trust | 0.01 % | as of Feb 28, 2026 ↗ |
| World ex U.S. Targeted Value Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional Emerging Markets Core Equity 2 ETF Dimensional ETF Trust | 0.00 % | as of Apr 30, 2026 ↗ |
| Avantis Emerging Markets Equity ETF American Century ETF Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| Dimensional Emerging Markets Sustainability Core 1 ETF Dimensional ETF Trust | 0.00 % | as of Apr 30, 2026 ↗ |
| Emerging Markets ex China Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 0.00 % | as of Apr 30, 2026 ↗ |
| DIMENSIONAL EMERGING MARKETS VALUE FUND DIMENSIONAL EMERGING MARKETS VALUE FUND | 0.00 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 14 | +1 | 694,630 | +16.5 % |
| 2026Q1 | 13 | +1 | 596,029 | +20.2 % |
| 2025Q4 | 12 | 0 | 495,683 | +22.6 % |
| 2025Q3 | 12 | 0 | 404,286 | +0.1 % |
| 2025Q2 | 12 | -2 | 404,033 | -40.0 % |
| 2025Q1 | 14 | +3 | 673,477 | +63.9 % |
| 2024Q4 | 11 | +4 | 410,938 | +13.1 % |
| 2024Q3 | 7 | +2 | 363,378 | +0.8 % |
| 2024Q2 | 5 | +1 | 360,346 | +9.0 % |
| 2024Q1 | 4 | -1 | 330,614 | -83.0 % |
| 2023Q4 | 5 | 1,941,471 |
Cite this page
Titelia. "Funds holding Bliss Gvs Pharma Ltd". https://titelia.com/en/stocks/bliss-gvs-pharma-ltd-INE416D01022